Carpal tunnel syndrome screening
|
Carpal tunnel syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carpal tunnel syndrome screening On the Web |
|
American Roentgen Ray Society Images of Carpal tunnel syndrome screening |
|
Risk calculators and risk factors for Carpal tunnel syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Dheeraj Makkar, M.D.[2]
Overview
Routine screening for CTS in the general population is not indicated. Instead, a targeted approach—using symptom questionnaires, physical exam maneuvers, and selective imaging or nerve conduction studies—is recommended for high-risk occupations and patients with systemic predispositions.
Screening in Carpal Tunnel Syndrome
Carpal tunnel syndrome is primarily a clinical diagnosis, and there are no population-based screening programs recommended for asymptomatic individuals. Instead, screening is generally targeted toward high-risk groups and focused on early detection of symptomatic disease to prevent progression.
- At-Risk Populations:
Workers exposed to repetitive wrist motions, vibrating tools, or prolonged computer use.
Patients with systemic risk factors: diabetes, hypothyroidism, obesity, rheumatoid arthritis, pregnancy, or amyloidosis.
- Screening Tools:
Symptom questionnaires and diagrams: The self-administered hand diagram is highly specific (~76%) for CTS.
- Provocative maneuvers: Phalen’s test, Tinel’s sign, and the carpal tunnel compression test (Durkan’s) are used in outpatient or occupational health settings for early identification.
- Sensory testing: Semmes–Weinstein monofilament testing and two-point discrimination may detect early sensory deficits.
- Electrodiagnostic studies: Not suitable for general screening, but used to confirm diagnosis in equivocal or high-risk cases.
- Ultrasound: Increasingly used for screening in selected groups, as it can demonstrate median nerve enlargement and structural causes noninvasively.